Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 651 - 700 out of 3,253

Document Document Title
WO/1992/010466A1
The present invention relates particularly to novel preorganized hexadentate ligands that are suitable for complexing with a radionuclide, and are useful as general imaging agents for diagnostic purposes. They have general formula (I), w...  
WO/1992/007558A1
The present invention provides novel substituted anthraquinones having formula (I), wherein R¿1? and R¿2? are independently H, alkyl, aryl, or arylalkyl; m and n are independently 1, 2, or 3; X is H, OH, NR¿3?R¿4?, Cl, Br, I, F, alky...  
WO/1992/007557A1
The present invention provides novel substituted anthraquinones having formula ($g(a)), wherein R¿1? and R¿2? are independently H, C¿1?-C¿10? alkyl, aryl, arylalkyl, alkylaryl, or R¿1? and R¿2? taken together with the adjacent nitr...  
WO1991018866A3  
WO/1992/006670A1
The object of the present invention are hair colorants containing at least one 1,4-bis-[(dihydroxyalkyl)amino]-anthrachinone of the general formula (I) in which R?1¿ and R?2¿ may be the same or different and mutually independently be a...  
WO/1992/005143A1
The present invention is concerned with compounds of formula (I), wherein R1 is hydrogen, hydroxy, C1-4 alkyl, halo (e.g., chloro), carbamoyl, aminosulfonyl, C1-4 alkylsulfonylamino or C1-4 alkyl(C1-4 alkylsulfonyl)amino; R2 is hydrogen,...  
WO/1992/004328A1
Compounds useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by compounds of formula (1.0) and their pharmaceutically acceptable salts and solvates. Pharm...  
WO/1992/004309A1
15,16-Seco-19-nor progestins are provided which display elevated progestational activity with a minimum of ancillary hormonal activity. Processes for the preparation of the novel progestins are provided as are methods of use. A preferred...  
WO/1992/003488A1
The fluorinated quinoline polymers comprising repeating units of one or more quinoline groups wherein at least a portion of the repeating units include a group selected from hexafluoroisopropylidene (6F) and 1-aryl-2,2,2-trifluoroethylid...  
WO/1992/002484A1
Compounds having anti-inflammatory and other activities are disclosed. The compounds are derived from diterpenes, aromatic heterocyclic compounds of the indole, indene, benzofuran and benzothiophene class and from polyacetates, diaminobe...  
WO/1992/002480A1
5-Hydroxy-benzo-(1',2')-cyclodeca-2,7-diyne-1-one and derivatives thereof and related fused ring diyneone macrocyclic compounds are disclosed. The compounds possess DNA-cleaving, antibiotic and tumor growth-inhibiting properties. Methods...  
WO/1991/018866A2
There are provided novel 1,4-diamine-2,3-dihydroxybutanes useful as antiviral agents, pharmaceutical compositions containing them and processes for preparing such compounds.  
WO/1991/016320A1
Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation and their use in the treatment of viral infections, in particular influenza, are described.  
WO/1991/013080A1
Pseudonucleosides and pseudonucleotides are useful in the synthesis of oligomers which contain these components as a means to derivatize the resulting oligonucleotide. In general, these pseudonucleotide components are of formula (1), whe...  
WO/1991/009594A1
The invention relates to methods for the treatment of schizophrenia or other psychoses by administering a pharmaceutical composition comprising an effective amount of certain sigma receptor ligands to a patient in need of such treatment....  
WO/1991/008198A1
This invention relates to optical elements capable of second harmonic generation and novel compositions for use in such optical elements comprising polar molecules placed in noncentrosymmetric configuration wherein such optical element h...  
WO/1991/007501A1
Process for the pancreatic lipase mediated transesterification method for the optical resolution of endo-norborneol; derived optically active 5-(3-(exo-bicyclo[2.2.1]hept-2-yloxy)-4-methoxyphenyl)-3,4,5 ,6-tetrahydropyrimidin-2(1H)-ones;...  
WO/1991/007371A1
The present invention relates to a method for the preparation of alpha,beta-unsaturated ketones represented by general formula (II) (where R is a heterocyclic group with nitrogen atom in the ring or a phenyl group with electron donative ...  
WO/1991/005824A1
Compounds of formula (I) in which R1, R2, R3 and R4 are each separately selected from hydrogen, X, NH-A-NHR and NH-A-N(O)R'R'' wherein X is hydroxy, halogeno, amino, C1-4 alkoxy or C2-8 alkanoyloxy, A is a C2-4 alkylene group with a chai...  
WO/1990/014330A1
A compound of formula (I), where Z is hydrogen or halogen, Q is COR1 or 5- or 6-membered aryl which may contain 1 or 2 heteroatoms selected from N, O or S and may be substituted or fused wherein R is hydrogen or C1-methyl (cis-configurat...  
WO/1990/009368A1
A method for producing amines, comprising contacting at reactive conditions at least one alcohol, aldehyde or ketone, or a mixture thereof, with an aminating agent in the presence of a catalyst, is improved by employing as the catalyst a...  
WO/1990/008759A1
The present invention concerns compounds of formula (I) wherein R1 is hydrogen, a hydroxy group or a methoxy group; R2 is hydrogen or a methyl group; R3 is hydrogen or a methyl group; Y is a secondary amino group (NHalkyl) or a tertiary ...  
WO/1990/006299A1
New phenylethanolamines of general formula (I), in which A is a straight-chain or branched alkylene group, B is a bond, an alkylene group, a carbonyl or hydroxymethylene group, R1 is a hydrogen atom, a halogen atom or a trifluormethyle g...  
WO/1990/004583A1
A muscarinic receptor antagonist, useful in treating irritable bowel syndrome, of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 is a group of formula (alpha) or (beta), where Z and Z1 are each independently hydro...  
WO/1989/012443A1
A compound of formula (I) and pharmaceutically acceptable acid addition salts thereof having antihistaminic activity wherein the various substituents are defined in the specification.  
WO/1989/003681A1
A racemic or optically active compound having the structural formula (I), wherein n is 0 or 1; X is CH2, O, S, SO, SO2, NH or N(C1-C4)alkyl; X1 is CH2, O, S, SO or SO2; Y and Y1 are taken together and form a carbonyl group, or Y and Y1 a...  
WO/1989/003819A1
Phenylcarboxylic acid derivatives represented by formula (I), and their salts, wherein R1 and R2 each represents H, halogen, alkyl, haloalkyl, alkanoyl, cycloalkyl, nitro, amino, -O-D-R5 (wherein D represents alkylene, and R5 represents ...  
WO/1989/003382A1
The invention comprises cyclobutarene ketoaniline monomers and the process for preparing them. The monomers can be used to graft and/or endcap a monomer or polymer having at least 1 amino-reactive functionality. The grafted and/or endcap...  
WO/1988/007036A1
Compound having beta-adrenergic blocking properties having formula (I), wherein X is -O-, -CH2- or -----; Y is =O or a derivatized keto group, each of which is hydrolyzable or enzymatically convertible to a ketonic group; R is alkyl havi...  
WO/1988/006580A1
Aryl-substituted tert.-alkylenamines, have the formula (I), where R is an alkyl group with 1-6 C-atoms, or the total residue (a) represents the heterocyclic residues (b), (c), (d), (e), or (f), where R5 is hydrogen, methyl, phenyl, 4-chl...  
WO1987007599A3  
WO/1987/007599A2
Compounds having anti-inflammatory and other activities. The compounds are derived from diterpenes, indol alkaloids, polyacetates, diaminobenzyl alcohols, diacylglycerol and bryostatins.  
WO/1987/006576A1
Antidepressant agents having formula (I), wherein R1 is a polycycloalkyl group; R2 is methyl or ethyl, X is O or NH; and Y comprises a 5- or 6-membered heterocyclic ring having one or two nitrogens; or fused bicyclic heterocyclic rings h...  
WO/1987/004153A1
2,3-Dihydro-1H-phenalene-2-amino compounds of formula (I), some of which are new, e.g., 2,3-dihydro-2-(N,N-di-n-propylamino)-1H-phenalen-5-ol, and pharmaceutically acceptable salts of such compounds have been found to be useful anti-psyc...  
WO/1987/003283A1
Carbacycline derivatives of general formula (I), in which Y1 is the residue of Formula (II), R9 is the residue -(CH2)m-R6 or the residue -(CH2)m-o- ADZ1-(CH2)m-p BDx- ADZ2-(CH2)m-q BDy-R6, m = 2-20; o, p and q <= 19; x, y = 0, 1 or 2; Z1...  
WO/1987/002980A1
The invention relates to the field of organic chemistry and particularly to a process for the synthesis of alpha-amino nitriles which comprises subjecting an RCN nitrile to the action of a metal reducing agent to form a metal imine, and ...  
WO/1986/005777A1
Compounds of the general formula (I) in which Z represents CR1R2(OR3) or phenyl with R1 H, C1-6 alkyl or phenyl, R2 H, C1-6 alkyl or C1-6 alkoxy, R3 H, C1-6 alkyl or C1-6 alkanoyl and Z' represents Y AD(CH2)m-X BD- with X CH2 or O, Y OH;...  
WO/1986/005778A1
Compounds of the general formula (I) in which Z represents CH1R2(OR3) or phenyl; R1 represents H, C1-6-alkyl or phenyl; R2 represents H, C1-6-alkyl or C1-6-alkoxy; R3 represents H, C1-6-alkyl or C1-6-alkanoyl and Z' represents Y- AD(CH2)...  
WO/1986/002350A1
A new and useful class of ultra light absorbing compounds and their use in sunscreen compositions and the protection of paint films and plastics materials from solar degradation. In particular the compounds possess a novel UV absorbing c...  
WO/1986/001502A1
A process for the production of amino compounds from hydroxyl compounds (Voelter reaction), according to which a hydroxyl compound is converted with trifluormethanesulphonic acid anhydride in water-free conditions, the corresponding trif...  
WO/1986/000895A1
Carbacycline derivatives of formula (I) are disclosed, wherein: n is 1 or 3, R1 is the rest having the formula (II), the rest having the formula (III), -COCH3, the rest COOR2 wherein R2 is hydrogen or alkyl with 1 to 10 atoms of carbon o...  
WO/1981/001407A1
Compounds of the formula (FORMULA) wherein R is H or CH3, n is 1 or 2 and X is F, Cl, Br, I bound in an optional position to the phenyl group, provided that when X is Br it is bound in a position other than the 4 position, processes for ...  
JP2019194214A
[Subject] Offer of new synthetic intermediate of a Cakero mycin derivative. [Means for Solution] A compound denoted by formula (4) and (5), or its salt.;n shows 0 or 1 for a hydrocarbon group or a heterocyclic machine with which R may be...  
JP6594873B2  
JP2019142922A
To provide aminoketones for photoinitiator systems for low migration inks, which provide good curability of energy curable coatings and inks with UV-A light.The invention provides aminoketones such as the formula in the figure, where eac...  
JP2019131563A
To provide: novel tetrahydro-isohumulone (THIAA) derivatives and substantially enantiomerically pure compositions and pharmaceutical formulations thereof; and methods of using the compounds and compositions to activate PPARγ, inhibit in...  
JPWO2018074411A1
A manufacturing method of an efficient economical nitrogen-containing compound is provided. It is formula NR to a compound denoted by a lower type (4).1R2A compound and this formula NR which make more than [which is denoted by C (O) H / ...  
JP2019126751A
To provide a chiral complex which, when used as a catalyst, can make an aromatic boronic acid undergo asymmetric 1,4-addition to a conjugated enone in an aqueous solvent under relatively mild conditions and can be recovered by filtration...  
JP6526275B2  
JP2019513707A
【解決手段】 本開示は、化学式Iおよび/または化学式I Iの化合物、またはその薬学的に許容される 塩:【化1】(式中、Dは重水素であり、各 重水素は約10%以上の...  

Matches 651 - 700 out of 3,253